Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Switching From Restasis to TRYPTYR in Dry Eye Disease
NCT07267299Phase 4Not yet recruiting
- Sponsor
- Southern College of Optometry
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of acoltremon in dry eye disease (DED), sponsored by Southern College of Optometry. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
acoltremon
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07267299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07267299.